Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2026-01-15 @ 3:11 PM
Study NCT ID:
NCT05029102
Status:
RECRUITING
Last Update Posted:
2024-02-12
First Post:
2021-08-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TAS-102 and Anlotinib in ≥3 Lines mGC
Sponsor:
Zhejiang University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
THALIA
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None